Effect of 7 vs 14 Days of Antibiotic Therapy on Resolution of Symptoms Among Afebrile Men With Urinary Tract Infection

医学 四分位间距 随机对照试验 安慰剂 环丙沙星 甲氧苄啶 泌尿系统 内科学 中止 人口 不利影响 意向治疗分析 磺胺甲恶唑 抗生素 外科 替代医学 环境卫生 病理 微生物学 生物
作者
Dimitri Drekonja,Barbara W. Trautner,Carla Amundson,Michael A. Kuskowski,James R. Johnson
出处
期刊:JAMA [American Medical Association]
卷期号:326 (4): 324-324 被引量:70
标识
DOI:10.1001/jama.2021.9899
摘要

Importance

Determination of optimal treatment durations for common infectious diseases is an important strategy to preserve antibiotic effectiveness.

Objective

To determine whether 7 days of treatment is noninferior to 14 days when using ciprofloxacin or trimethoprim/sulfamethoxazole to treat urinary tract infection (UTI) in afebrile men.

Design, Setting, and Participants

Randomized, double-blind, placebo-controlled noninferiority trial of afebrile men with presumed symptomatic UTI treated with ciprofloxacin or trimethoprim/sulfamethoxazole at 2 US Veterans Affairs medical centers (enrollment, April 2014 through December 2019; final follow-up, January 28, 2020). Of 1058 eligible men, 272 were randomized.

Interventions

Participants continued the antibiotic prescribed by their treating clinician for 7 days of treatment and were randomized to receive continued antibiotic therapy (n = 136) or placebo (n = 136) for days 8 to 14 of treatment.

Main Outcomes and Measures

The prespecified primary outcome was resolution of UTI symptoms by 14 days after completion of active antibiotic treatment. A noninferiority margin of 10% was selected. The as-treated population (participants who took ≥26 of 28 doses and missed no more than 2 consecutive doses) was used for the primary analysis, and a secondary analysis included all patients as randomized, regardless of treatment adherence. Secondary outcomes included recurrence of UTI symptoms and/or adverse events within 28 days of stopping study medication.

Results

Among 272 patients (median [interquartile range] age, 69 [62-73] years) who were randomized, 100% completed the trial and 254 (93.4%) were included in the primary as-treated analysis. Symptom resolution occurred in 122/131 (93.1%) participants in the 7-day group vs 111/123 (90.2%) in the 14-day group (difference, 2.9% [1-sided 97.5% CI, –5.2% to ∞]), meeting the noninferiority criterion. In the secondary as-randomized analysis, symptom resolution occurred in 125/136 (91.9%) participants in the 7-day group vs 123/136 (90.4%) in the 14-day group (difference, 1.5% [1-sided 97.5% CI, –5.8% to ∞]) Recurrence of UTI symptoms occurred in 13/131 (9.9%) participants in the 7-day group vs 15/123 (12.9%) in the 14-day group (difference, –3.0% [95% CI, –10.8% to 6.2%];P = .70). Adverse events occurred in 28/136 (20.6%) participants in the 7-day group vs 33/136 (24.3%) in the 14-day group.

Conclusions and Relevance

Among afebrile men with suspected UTI, treatment with ciprofloxacin or trimethoprim/sulfamethoxazole for 7 days was noninferior to 14 days of treatment with regard to resolution of UTI symptoms by 14 days after antibiotic therapy. The findings support the use of a 7-day course of ciprofloxacin or trimethoprim/sulfamethoxazole as an alternative to a 14-day course for treatment of afebrile men with UTI.

Trial Registration

ClinicalTrials.gov identifier:NCT01994538
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Ava应助坚定路人采纳,获得10
1秒前
3秒前
4秒前
潘善若发布了新的文献求助10
4秒前
戴岱发布了新的文献求助10
6秒前
7秒前
8秒前
momo发布了新的文献求助10
10秒前
大模型应助潘善若采纳,获得10
10秒前
11秒前
jolt发布了新的文献求助10
12秒前
13秒前
传奇3应助戴岱采纳,获得10
14秒前
nini完成签到,获得积分10
16秒前
zzzjh发布了新的文献求助10
16秒前
量子星尘发布了新的文献求助10
17秒前
17秒前
19秒前
20秒前
nini发布了新的文献求助10
23秒前
Lucas应助XAN采纳,获得10
24秒前
潘善若发布了新的文献求助10
24秒前
棠棠完成签到 ,获得积分10
24秒前
27秒前
yyer完成签到,获得积分10
27秒前
29秒前
FashionBoy应助潘善若采纳,获得10
30秒前
慕青应助忐忑的阑香采纳,获得10
30秒前
momo发布了新的文献求助10
31秒前
冰淇淋完成签到,获得积分10
31秒前
XylonYu完成签到,获得积分10
32秒前
34秒前
坚定路人发布了新的文献求助10
36秒前
张宁波完成签到,获得积分0
37秒前
sue完成签到,获得积分10
38秒前
39秒前
慕青应助害羞的山柏采纳,获得10
40秒前
平常的可乐完成签到 ,获得积分10
42秒前
深情安青应助momo采纳,获得10
43秒前
852应助王汉韬采纳,获得10
43秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989297
求助须知:如何正确求助?哪些是违规求助? 3531418
关于积分的说明 11253893
捐赠科研通 3270097
什么是DOI,文献DOI怎么找? 1804884
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809158